Prior studies have described divergent functions of IL-6, ranging from growth-inhibitory activity in certain breast cancer cell lines [61,81,82] to growth-promoting or drug-resistance-associated effects in MCF-7 cells [83]. The gene discussed is IL6; the disease is breast carcinoma.